Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 8 | 2023 | 427 | 4.290 |
Why?
|
| Artificial Intelligence | 8 | 2023 | 429 | 3.870 |
Why?
|
| Intestinal Volvulus | 7 | 2024 | 36 | 2.400 |
Why?
|
| Digestive System Abnormalities | 7 | 2024 | 41 | 2.220 |
Why?
|
| Ultrasonography | 11 | 2024 | 1931 | 1.940 |
Why?
|
| Radiology Information Systems | 3 | 2024 | 122 | 1.550 |
Why?
|
| Intestinal Obstruction | 2 | 2024 | 224 | 1.530 |
Why?
|
| Radiologists | 7 | 2022 | 180 | 1.430 |
Why?
|
| Foreign Bodies | 3 | 2021 | 160 | 1.360 |
Why?
|
| Child | 36 | 2024 | 30558 | 1.090 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2023 | 7787 | 1.020 |
Why?
|
| Pediatrics | 4 | 2024 | 1194 | 0.960 |
Why?
|
| Intussusception | 2 | 2022 | 51 | 0.900 |
Why?
|
| Device Approval | 1 | 2023 | 18 | 0.880 |
Why?
|
| Appendicitis | 2 | 2024 | 177 | 0.870 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 60 | 0.840 |
Why?
|
| Workflow | 2 | 2021 | 278 | 0.840 |
Why?
|
| Radiation Protection | 1 | 2023 | 204 | 0.800 |
Why?
|
| Pandemics | 5 | 2022 | 1608 | 0.800 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2023 | 125 | 0.780 |
Why?
|
| Clinical Decision-Making | 1 | 2024 | 536 | 0.730 |
Why?
|
| Teleradiology | 1 | 2020 | 13 | 0.710 |
Why?
|
| Multi-Institutional Systems | 1 | 2020 | 13 | 0.710 |
Why?
|
| Radiology Department, Hospital | 2 | 2020 | 53 | 0.710 |
Why?
|
| Duodenum | 1 | 2021 | 169 | 0.710 |
Why?
|
| Thyroid Nodule | 1 | 2021 | 92 | 0.700 |
Why?
|
| Nuclear Medicine | 1 | 2020 | 28 | 0.700 |
Why?
|
| Radiography | 7 | 2023 | 1993 | 0.680 |
Why?
|
| Hospitals, Community | 1 | 2020 | 76 | 0.680 |
Why?
|
| Fractures, Bone | 1 | 2022 | 310 | 0.680 |
Why?
|
| Outpatients | 1 | 2023 | 463 | 0.670 |
Why?
|
| Shift Work Schedule | 1 | 2019 | 19 | 0.660 |
Why?
|
| Child Health Services | 1 | 2020 | 88 | 0.660 |
Why?
|
| Burnout, Professional | 1 | 2023 | 222 | 0.640 |
Why?
|
| Hospitals, Pediatric | 2 | 2022 | 796 | 0.630 |
Why?
|
| Diagnostic Imaging | 4 | 2024 | 1174 | 0.630 |
Why?
|
| Play and Playthings | 1 | 2018 | 20 | 0.620 |
Why?
|
| Digestive System | 1 | 2018 | 120 | 0.600 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2021 | 586 | 0.580 |
Why?
|
| Humans | 47 | 2024 | 270601 | 0.510 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2018 | 238 | 0.500 |
Why?
|
| Referral and Consultation | 1 | 2021 | 930 | 0.490 |
Why?
|
| Quality Assurance, Health Care | 1 | 2019 | 593 | 0.470 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 1300 | 0.440 |
Why?
|
| Societies, Medical | 3 | 2024 | 1322 | 0.400 |
Why?
|
| Clinical Competence | 1 | 2019 | 1331 | 0.370 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 12038 | 0.360 |
Why?
|
| Whole Body Imaging | 1 | 2011 | 120 | 0.350 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 1894 | 0.350 |
Why?
|
| Laryngitis | 1 | 2009 | 6 | 0.340 |
Why?
|
| Tracheitis | 1 | 2009 | 19 | 0.340 |
Why?
|
| Croup | 1 | 2009 | 16 | 0.340 |
Why?
|
| Bronchitis | 1 | 2009 | 43 | 0.340 |
Why?
|
| Sensitivity and Specificity | 6 | 2023 | 5157 | 0.330 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 7912 | 0.320 |
Why?
|
| Hospitals | 2 | 2023 | 482 | 0.320 |
Why?
|
| Radiation Dosage | 4 | 2023 | 1042 | 0.320 |
Why?
|
| Infant | 12 | 2024 | 13992 | 0.320 |
Why?
|
| Retrospective Studies | 13 | 2024 | 39922 | 0.300 |
Why?
|
| Heart Injuries | 1 | 2007 | 51 | 0.290 |
Why?
|
| Child, Preschool | 11 | 2024 | 17075 | 0.280 |
Why?
|
| Thoracic Injuries | 1 | 2007 | 98 | 0.280 |
Why?
|
| Hematoma | 1 | 2007 | 156 | 0.270 |
Why?
|
| Angiography | 1 | 2007 | 349 | 0.260 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2007 | 221 | 0.250 |
Why?
|
| Positron-Emission Tomography | 2 | 2011 | 2199 | 0.250 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 5923 | 0.240 |
Why?
|
| Aorta | 1 | 2007 | 666 | 0.220 |
Why?
|
| Infant, Newborn | 5 | 2024 | 8602 | 0.210 |
Why?
|
| Vascular Malformations | 1 | 2024 | 88 | 0.210 |
Why?
|
| Urography | 2 | 2013 | 57 | 0.210 |
Why?
|
| Dissent and Disputes | 1 | 2022 | 40 | 0.200 |
Why?
|
| Lymphoma | 1 | 2011 | 1516 | 0.200 |
Why?
|
| Ileal Diseases | 1 | 2022 | 27 | 0.200 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 6193 | 0.190 |
Why?
|
| Adolescent | 10 | 2023 | 32684 | 0.190 |
Why?
|
| Esophagus | 2 | 2021 | 562 | 0.180 |
Why?
|
| Quarantine | 1 | 2020 | 23 | 0.180 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2023 | 382 | 0.170 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 88 | 0.170 |
Why?
|
| Workload | 1 | 2021 | 193 | 0.170 |
Why?
|
| Triage | 1 | 2021 | 252 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 417 | 0.160 |
Why?
|
| Intestines | 1 | 2024 | 727 | 0.160 |
Why?
|
| Eye | 1 | 2021 | 284 | 0.160 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 205 | 0.160 |
Why?
|
| Observer Variation | 1 | 2021 | 709 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 964 | 0.150 |
Why?
|
| Infection Control | 1 | 2020 | 279 | 0.150 |
Why?
|
| Contrast Media | 2 | 2021 | 1505 | 0.140 |
Why?
|
| Adult | 5 | 2023 | 81960 | 0.140 |
Why?
|
| Patient Safety | 1 | 2022 | 612 | 0.140 |
Why?
|
| United States | 4 | 2024 | 15827 | 0.140 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2018 | 379 | 0.130 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2011 | 1260 | 0.120 |
Why?
|
| Betacoronavirus | 1 | 2020 | 514 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 4838 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 2 | 2024 | 2394 | 0.120 |
Why?
|
| Software | 1 | 2021 | 1357 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 819 | 0.110 |
Why?
|
| Urination | 1 | 2013 | 34 | 0.110 |
Why?
|
| Urethra | 1 | 2013 | 167 | 0.100 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 623 | 0.100 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2013 | 88 | 0.100 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 701 | 0.100 |
Why?
|
| Male | 13 | 2024 | 128395 | 0.100 |
Why?
|
| Algorithms | 1 | 2023 | 3906 | 0.100 |
Why?
|
| Female | 12 | 2024 | 148790 | 0.100 |
Why?
|
| Young Adult | 4 | 2022 | 22219 | 0.090 |
Why?
|
| Urologic Diseases | 1 | 2011 | 84 | 0.090 |
Why?
|
| Fluoroscopy | 1 | 2011 | 225 | 0.090 |
Why?
|
| Brain | 1 | 2023 | 4201 | 0.080 |
Why?
|
| Documentation | 1 | 2011 | 213 | 0.080 |
Why?
|
| Texas | 1 | 2020 | 6445 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2018 | 6234 | 0.080 |
Why?
|
| Radiometry | 1 | 2013 | 1020 | 0.070 |
Why?
|
| Aortography | 1 | 2007 | 173 | 0.070 |
Why?
|
| Radiopharmaceuticals | 1 | 2011 | 1341 | 0.060 |
Why?
|
| Hypotension | 1 | 2006 | 225 | 0.060 |
Why?
|
| Craniotomy | 1 | 2006 | 303 | 0.060 |
Why?
|
| Intraoperative Complications | 1 | 2006 | 287 | 0.060 |
Why?
|
| Short Bowel Syndrome | 1 | 2024 | 62 | 0.060 |
Why?
|
| Vascular Neoplasms | 1 | 2024 | 112 | 0.050 |
Why?
|
| Hemangioma | 1 | 2024 | 160 | 0.050 |
Why?
|
| Necrosis | 1 | 2024 | 591 | 0.050 |
Why?
|
| Enema | 1 | 2022 | 49 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2006 | 773 | 0.040 |
Why?
|
| Bronchi | 1 | 2021 | 325 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 63 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 310 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2024 | 1027 | 0.040 |
Why?
|
| Body Composition | 1 | 2022 | 602 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2021 | 402 | 0.040 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2024 | 930 | 0.040 |
Why?
|
| Length of Stay | 1 | 2024 | 1997 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 15270 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 14021 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 1175 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2007 | 6762 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2022 | 2227 | 0.030 |
Why?
|
| Risk Factors | 2 | 2007 | 17855 | 0.030 |
Why?
|
| Washington | 1 | 2013 | 74 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1256 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2024 | 33811 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 4493 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 481 | 0.020 |
Why?
|
| Injections | 1 | 2011 | 284 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 1307 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 31084 | 0.020 |
Why?
|
| Time Factors | 2 | 2011 | 12971 | 0.020 |
Why?
|
| Methyl Ethers | 1 | 2006 | 28 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 1287 | 0.020 |
Why?
|
| Isoflurane | 1 | 2006 | 65 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 13413 | 0.020 |
Why?
|
| Fentanyl | 1 | 2006 | 152 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 2006 | 224 | 0.020 |
Why?
|
| Aged | 1 | 2007 | 73534 | 0.010 |
Why?
|
| Middle Aged | 1 | 2007 | 90450 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 5441 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 15931 | 0.000 |
Why?
|